Xemed LLC is a diagnostic drug company specializing in hyperpolarized gas MRI technology, collaborating with clinical researchers, pharmaceutical companies, and the NIH to advance pulmonary functional imaging for commercialization.
With a strong focus on product development, Xemed aims to revolutionize the diagnosis and treatment of respiratory conditions such as COPD, asthma, and lung cancer through their innovative pipeline products and medical devices.
Generated from the website